6-hydroxydopa has been researched along with oxidopamine in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (36.36) | 18.7374 |
1990's | 5 (45.45) | 18.2507 |
2000's | 1 (9.09) | 29.6817 |
2010's | 1 (9.09) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cohen, G; Evans, JM | 1 |
Kostrzewa, RM | 2 |
Smith, GC; Willis, GL | 1 |
Jaim-Etcheverry, G; Zieher, LM | 1 |
Nappi, AJ; Vass, E | 1 |
Chrapusta, SJ; Egan, MF; Karoum, F; Wyatt, RJ | 1 |
Lin, JY; Mai, LM; Pan, JT | 1 |
Cohen, G; Evans, J | 1 |
Memoli, S; Nappi, AJ; Prota, G; Vass, E | 1 |
Berta, B; Gálosi, R; Kállai, V; Kovács, A; Lénárd, L; Ollmann, T; Péczely, L; Petykó, Z; Tóth, A | 1 |
3 review(s) available for 6-hydroxydopa and oxidopamine
Article | Year |
---|---|
Reorganization of noradrenergic neuronal systems following neonatal chemical and surgical injury.
Topics: Adrenergic Fibers; Animals; Benzylamines; Brain; Dihydroxyphenylalanine; Guanethidine; Hydroxydopamines; Mice; Neurotoxins; Norepinephrine; Oxidopamine; Rats | 1988 |
Amine accumulation in behavioural pathology.
Topics: Animals; Behavior, Animal; Brain; Catecholamines; Cats; Colchicine; Consummatory Behavior; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Dopamine beta-Hydroxylase; Histocytochemistry; Hydroxydopamines; Hypothalamic Area, Lateral; Hypothalamus; Kainic Acid; Medial Forebrain Bundle; Neural Pathways; Oxidopamine; Peripheral Nerves; Rats; Receptors, Dopamine; Serotonin; Substantia Nigra | 1985 |
Evolution of neurotoxins: from research modalities to clinical realities.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adrenergic Agents; Animals; Benzylamines; Botulinum Toxins, Type A; Dihydroxyphenylalanine; Dihydroxytryptamines; Glutamic Acid; Humans; Models, Animal; Nerve Growth Factor; Neurosciences; Neurotoxins; Oxidopamine; Terminology as Topic | 2009 |
8 other study(ies) available for 6-hydroxydopa and oxidopamine
Article | Year |
---|---|
Studies on the formation of 6-hydroxydopamine in mouse brain after administration of 2,4,5-trihydroxyphenylalanine (6-hydroxyDOPA).
Topics: Animals; Brain; Carbidopa; Cerebral Cortex; Chromatography, High Pressure Liquid; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Frontal Lobe; Hydroxydopamines; Male; Mice; Norepinephrine; Oxidopamine; Pargyline; Reserpine; Synaptic Vesicles | 1989 |
Neurotoxins and developing monoaminergic neurons.
Topics: Adrenergic Fibers; Amines; Animals; Animals, Newborn; Benzylamines; Blood-Brain Barrier; Dihydroxyphenylalanine; Hydroxydopamines; Nervous System; Oxidopamine; Rats | 1983 |
The effects of glutathione and ascorbic acid on the oxidations of 6-hydroxydopa and 6-hydroxydopamine.
Topics: Antioxidants; Ascorbic Acid; Dihydroxyphenylalanine; Glutathione; Models, Chemical; Oxidation-Reduction; Oxidopamine | 1994 |
Absence of 6-hydroxydopamine in the rat brain after treatment with stimulants and other dopaminergic agents: a mass fragmentographic study.
Topics: Animals; Brain; Carbidopa; Corpus Striatum; Dihydroxyphenylalanine; Dopamine Agents; Drug Combinations; Drug Stability; Frontal Lobe; Gas Chromatography-Mass Spectrometry; Injections, Intraventricular; Male; Oxidopamine; Pargyline; Rats; Rats, Sprague-Dawley; Stimulation, Chemical | 1993 |
Effects of systemic administration of 6-hydroxydopamine, 6-hydroxydopa and 1-methyl-4-phenyl-1,2,3,6-tetrahydroxypyridine (MPTP) on tuberoinfundibular dopaminergic neurons in the rat.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Arcuate Nucleus of Hypothalamus; Dihydroxyphenylalanine; Dopamine; Dose-Response Relationship, Drug; Neurons; Oxidopamine; Rats | 1993 |
Catecholamine uptake inhibitors elevate 6-hydroxydopamine in brain after administration of 6-hydroxydopa.
Topics: Animals; Axons; Brain; Catecholamines; Cerebral Cortex; Chromatography, High Pressure Liquid; Desipramine; Dihydroxyphenylalanine; Membranes; Mice; Nerve Endings; Neurons; Nomifensine; Oxidopamine | 1993 |
The effects of hydroxyl radical attack on dopa, dopamine, 6-hydroxydopa, and 6-hydroxydopamine.
Topics: Benzoquinones; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Dopamine; Hydroxyl Radical; Melanins; Models, Chemical; Oxidation-Reduction; Oxidopamine; Quinones | 1995 |
Destruction of noradrenergic terminals increases dopamine concentration and reduces dopamine metabolism in the medial prefrontal cortex.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic alpha-2 Receptor Antagonists; Animals; Dihydroxyphenylalanine; Dopamine; Dopamine Uptake Inhibitors; Extracellular Space; Male; Neural Pathways; Neurons; Norepinephrine; Oxidopamine; Piperazines; Prefrontal Cortex; Rats, Wistar; Yohimbine | 2018 |